# OXYTROL FOR WOMEN
> **NDA202211** · New Drug Application · Sponsor: ABBVIE · Approved 2013-01-25
## Drug
- **FDA Application Number:** NDA202211
- **Application type:** New Drug Application
- **Brand name:** OXYTROL FOR WOMEN
- **Generic name:** OXYBUTYNIN
- **Active ingredients:** OXYBUTYNIN
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Over-the-counter
- **Sponsor:** ABBVIE
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2013-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202211)
---
*AI Analytics · CC0 1.0*